🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsRetatrutide Phase 2 dose-response analysis — need advice Page 4

Retatrutide Phase 2 dose-response analysis — need advice

SarahChen_PharmD Sun, Jun 16, 2024 at 8:40 PM 55 replies 2,123 viewsPage 4 of 11
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jun 17, 2024 at 2:20 AM#16

Just wanted to say — for anyone reading this Retatrutide Phase 2 thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jun 17, 2024 at 6:20 AM
17 16FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 14 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Jun 17, 2024 at 2:37 AM#17

SarahChen_PharmD's experience with Retatrutide Phase 2 resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 38 lbs in 13 months.

One thing I would add that SarahChen_PharmD did not mention: the mental health improvements were just as significant.

33 1FranDenver, Dr.BariatricHTX, LindaRN_retired and 30 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Jun 17, 2024 at 2:54 AM#18

Saving this for reference. Top-tier content.

35 2BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 32 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jun 17, 2024 at 3:11 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Retatrutide Phase 2 dose-response.

Building on what SarahChen_PharmD said — the evidence base here is robust. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Jun 17, 2024 at 4:11 AM
50 16DebRD_ATL, KristenIndy, MarkLI_maint and 47 others
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Jun 17, 2024 at 3:28 AM#20

Subscribing to this thread. Retatrutide Phase 2 is exactly what I've been researching. 🙏

Last edited: Jun 17, 2024 at 4:28 AM
21 6kevin_tulsa, Dr.PainCLE, mike_mealprep and 18 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register